Making artificial blood for transfusions

April 19, 2017

Blood transfusions can save the lives of patients who have suffered major blood loss, but hospitals don't always have enough or the right type on hand. In search of a solution, researchers have developed a promising substitute using blood's oxygen-carrying component, hemoglobin. The in vitro study, reported in ACS' journal Biomacromolecules, found that the modified hemoglobin was an effective oxygen carrier and also scavenged for potentially damaging free radicals.

Red blood cells are the most commonly transfused component of blood, according to the U.S. National Heart, Lung, and Blood Institute. These cells carry the protein hemoglobin, which performs the essential function of delivering oxygen to the body's tissues. Scientists have tried developing chemically modified hemoglobin -- which by itself is toxic -- as a blood substitute but have found that it forms methemoglobin. This form of the protein doesn't bind oxygen and thus decreases the amount of oxygen that blood delivers in the body. In addition, the generation of methemoglobin produces hydrogen peroxide, which leads to cell damage. Hong Zhou, Lian Zhao, Yan Wu and colleagues wanted to see if packaging hemoglobin in a benign envelope could get around these problems.

The researchers developed a one-step method for wrapping hemoglobin in polydopamine, or PDA, which has been widely studied for biomedical applications. A battery of lab tests showed that the PDA-coated hemoglobin effectively carried oxygen, while preventing the formation of methemoglobin and hydrogen peroxide. In addition, it caused minimal cell damage, and acted as an effective antioxidant, scavenging for potentially damaging free radicals and reactive oxygen species.
-end-
The authors acknowledge funding from the National Natural Science Foundation of China and the Beijing Natural Science Foundation.

The abstract that accompanies this study is available here.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With nearly 157,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Follow us on Twitter | Facebook

American Chemical Society

Related Hemoglobin Articles from Brightsurf:

Tibetan antelope thrive at high altitudes using a juvenile form of blood oxygen transport
Adult Tibetan antelope have overcome oxygen deprivation on the high-altitude Tibetan Plateau through an unusual adaptation in which they permanently express a form of hemoglobin (the iron-containing oxygen transport protein in red blood cells) that other members of the cattle family only express as juveniles or when under extreme oxygen deprivation.

New mobile health tool measures hemoglobin without drawing blood
Researchers have developed a way to use smartphone images of a person's eyelids to assess blood hemoglobin levels.

Researchers reveal origins of complex hemoglobin by resurrecting ancient proteins
Researchers trace the evolutionary origins of hemoglobin by resurrecting ancient proteins from more than 400 million years ago.

How malaria parasites become resistant to artemisinin antimalarial drugs
Malaria parasite mutations that inhibit the endocytoic appetite for a host's red blood cells may render them resistant to artemisinin, a widely used frontline antimalarial drug, according to a new study, which reveals a key molecular mechanism of drug resistance.

Protein in blood protects against neuronal damage after brain hemorrhage
Patients who survive a cerebral hemorrhage may suffer delayed severe brain damage caused by free hemoglobin, which comes from red blood cells and damages neurons.

Both low and high levels of hemoglobin linked to increased risk of dementia
Having either low or high levels of hemoglobin in your blood may be linked to an increased risk of developing dementia years later, according to a study published in the July 31, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.

UH researcher reports the way sickle cells form may be key to stopping them
University of Houston chemist Vassiliy Lubchenko is reporting a new finding in Nature Communications on how sickle cells are formed, which may lead not only to stopping their formation, but to new avenues for making uniformly-sized nanoparticles for industry.

Athletes with sickle cell traits are at more risk to collapse: here's why
A genetic variation known to affect sickle cell disease might be the reason why some college football players experience adverse clinical outcomes during periods of extreme physical exertion and others do not.

Application of nanosized LiFePO4 modified electrode to electrochemical sensor & biosensor
The aim of this paper was to construct nanosized LFP modified electrodes, which could be applied as working electrode for rutin analysis and as an electrochemical biosensor for direct electrochemistry of Hemoglobin (Hb).

New portable blood analyzer could improve anemia detection worldwide
To reduce the burden of anemia, health officials need a better picture of the disease's global impact, an understanding made viable by a portable and affordable way to analyze blood.

Read More: Hemoglobin News and Hemoglobin Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.